Oct 21 2010

Investor Group Plans Bid for Boston Globe

Will Aaron Kushner finally take The Boston Globe off The New York Times Company’s hands? Mr. Kushner, the owner of the privately held Marian Heath Greeting Cards, told The Globe on Wednesday that he had corralled an investor group to buy the newspaper and associated properties, including The Worcester Telegram & Gazette. While the group [...]


Oct 10 2010

Massachusetts Candidate Tim Cahill Sues Ex-Strategists

Timothy Cahill, the independent candidate for governor in Massachusetts, has filed a lawsuit accusing his former top strategists of plotting to doom his campaign by helping his running mate resign and conspiring to give damaging information to his Republican rival, The Boston Globe reported. The suit filed Thursday points to e-mails in which the strategists [...]


Sep 26 2010

New Polls Show Trouble Signs for Deval Patrick in Massachusetts Governor’s Race

A pair of new polls both show a competitive Massachusetts governor’s race, but one has Democratic incumbent Deval Patrick just one point ahead of Republican Charlie Baker, while the other gives him a 6 point cushion. A Boston Globe poll conducted Sept. 17-22 has Patrick in a statistical tie with Baker, leading him by 35 [...]


Sep 1 2010

What Price Is Right for Genzyme?

The chief executive of Genzyme, Henri A. Termeer, on Tuesday appeared to soften his tone about a possible sale, a day after his company rejected a $69-a-share offer from Sanofi-Aventis. In an interview with The Boston Globe, Mr. Termeer acknoweldged that Genzyme was now in play even as he reiterated that Sanofi’s price undervalued the [...]


Sep 1 2010

What Price Is Right for Genzyme?

The chief executive of Genzyme, Henri A. Termeer, on Tuesday appeared to soften his tone about a possible sale, a day after his company rejected a $69-a-share offer from Sanofi-Aventis. In an interview with The Boston Globe, Mr. Termeer acknoweldged that Genzyme was now in play even as he reiterated that Sanofi’s price undervalued the [...]


Sep 1 2010

What Price Is Right for Genzyme?

The chief executive of Genzyme, Henri A. Termeer, on Tuesday appeared to soften his tone about a possible sale, a day after his company rejected a $69-a-share offer from Sanofi-Aventis. In an interview with The Boston Globe, Mr. Termeer acknoweldged that Genzyme was now in play even as he reiterated that Sanofi’s price undervalued the [...]